0000784199-24-000134.txt : 20240314
0000784199-24-000134.hdr.sgml : 20240314
20240314201450
ACCESSION NUMBER: 0000784199-24-000134
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240223
FILED AS OF DATE: 20240314
DATE AS OF CHANGE: 20240314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mackin James P
CENTRAL INDEX KEY: 0001408470
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13165
FILM NUMBER: 24752145
MAIL ADDRESS:
STREET 1: ARTIVION, INC.
STREET 2: 1655 ROBERTS BLVD, NW
CITY: KENNESAW
STATE: GA
ZIP: 30144
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARTIVION, INC.
CENTRAL INDEX KEY: 0000784199
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 592417093
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
CITY: KENNESAW
STATE: GA
ZIP: 30144
BUSINESS PHONE: 7704193355
MAIL ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
CITY: KENNESAW
STATE: GA
ZIP: 30144
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOLIFE INC
DATE OF NAME CHANGE: 19940526
4/A
1
wk-form4a_1710461680.xml
FORM 4/A
X0508
4/A
2024-02-23
2024-02-28
0
0000784199
ARTIVION, INC.
AORT
0001408470
Mackin James P
ARTIVION, INC.
1655 ROBERTS BLVD, NW
KENNESAW
GA
30144
0
1
0
0
President & CEO
0
Common Stock
2024-02-23
4
A
0
40404
0
A
668441
D
Common Stock
2024-02-26
4
S
0
17868
20.2711
D
650573
D
Common Stock
2024-02-23
4
A
0
58648
0
A
709221
D
Common Stock
2024-02-26
4
S
0
12968
20.2711
D
696253
D
Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.
These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 18,144 shares were sold, when in fact, 17,868 shares were sold.
As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.
Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.
These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 13,168 shares were sold, when in fact, 12,968 shares were sold.
/s/ James P. Mackin
2024-03-14